These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16533713)

  • 1. Oncology exploration: charting cancer medicinal chemistry space.
    Lloyd DG; Golfis G; Knox AJ; Fayne D; Meegan MJ; Oprea TI
    Drug Discov Today; 2006 Feb; 11(3-4):149-59. PubMed ID: 16533713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new rapid and effective chemistry space filter in recognizing a druglike database.
    Zheng S; Luo X; Chen G; Zhu W; Shen J; Chen K; Jiang H
    J Chem Inf Model; 2005; 45(4):856-62. PubMed ID: 16045278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of chemical compounds by protein-compound docking for use in designing a focused library.
    Fukunishi Y; Mikami Y; Takedomi K; Yamanouchi M; Shima H; Nakamura H
    J Med Chem; 2006 Jan; 49(2):523-33. PubMed ID: 16420039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity searching and scaffold hopping in synthetically accessible combinatorial chemistry spaces.
    Boehm M; Wu TY; Claussen H; Lemmen C
    J Med Chem; 2008 Apr; 51(8):2468-80. PubMed ID: 18380426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient in silico screening method based on the protein-compound affinity matrix and its application to the design of a focused library for cytochrome P450 (CYP) ligands.
    Fukunishi Y; Hojo S; Nakamura H
    J Chem Inf Model; 2006; 46(6):2610-22. PubMed ID: 17125201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing combinatorial libraries optimized on multiple objectives.
    Gillet VJ
    Methods Mol Biol; 2004; 275():335-54. PubMed ID: 15141120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural product-like libraries based on non-aromatic, polycyclic motifs.
    Messer R; Fuhrer CA; Häner R
    Curr Opin Chem Biol; 2005 Jun; 9(3):259-65. PubMed ID: 15939327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational chemistry-driven decision making in lead generation.
    Schnecke V; Boström J
    Drug Discov Today; 2006 Jan; 11(1-2):43-50. PubMed ID: 16478690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM; Bernardo PH; Chai CL; Tong JC
    J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Known drug space as a metric in exploring the boundaries of drug-like chemical space.
    Mirza A; Desai R; Reynisson J
    Eur J Med Chem; 2009 Dec; 44(12):5006-11. PubMed ID: 19782440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting compounds for focused screening using linear discriminant analysis and artificial neural networks.
    Ford MG; Pitt WR; Whitley DC
    J Mol Graph Model; 2004 Jul; 22(6):467-72. PubMed ID: 15182805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible 3D pharmacophores as descriptors of dynamic biological space.
    Nettles JH; Jenkins JL; Williams C; Clark AM; Bender A; Deng Z; Davies JW; Glick M
    J Mol Graph Model; 2007 Oct; 26(3):622-33. PubMed ID: 17395510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fast exchange algorithm for designing focused libraries in lead optimization.
    Le Bailly de Tilleghem C; Beck B; Boulanger B; Govaerts B
    J Chem Inf Model; 2005; 45(3):758-67. PubMed ID: 15921465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How good is your screening library?
    Irwin JJ
    Curr Opin Chem Biol; 2006 Aug; 10(4):352-6. PubMed ID: 16797220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing a multiroute synthesis scheme in combinatorial chemistry.
    Akavia A; Senderowitz H; Lerner A; Shamir R
    J Comb Chem; 2004; 6(4):540-8. PubMed ID: 15244415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational analysis of ligand relationships within target families.
    Bajorath J
    Curr Opin Chem Biol; 2008 Jun; 12(3):352-8. PubMed ID: 18312862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular underpinnings of the targeted therapy for cancer.
    Wcisło G
    Acta Pol Pharm; 2008; 65(6):633-40. PubMed ID: 19172844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.